MLICM
EVLO

Metropolitan Life Insurance Company (MetLife)’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-447
Closed -$123K – 2856
2021
Q2 		$123K Buy
+447
New +$113K ﹤0.01% 2487

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EVLO Position: Q3 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2021, closing a stake of 447 shares — an estimated $123K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EVLO in Q2 2021 and held it in 1 quarter. The position peaked at $123K in Q2 2021. 64 funds tracked by Wall St. Rank hold EVLO as of Q3 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 447 Evelo Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $123K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s Evelo Biosciences, Inc. Common Stock position peaked at $123K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.